XML 17 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
Revenues $ 208,357 $ 198,533 $ 190,884
Cost of Sales (197,173) (187,262) (179,468)
Gross Profit 11,184 11,271 11,416
Operating Expenses      
Selling, distribution and administrative expenses (8,138) (7,460) (7,379)
Research and development (125) (341) (392)
Goodwill impairment charges (1,738) (290) 0
Restructuring and asset impairment charges (567) (18) (203)
Total Operating Expenses (10,422) (4,162) (7,871)
Operating Income 762 7,109 3,545
Other Income, Net 130 90 58
Loss on Debt Extinguishment (122) 0 0
Interest Expense (283) (308) (353)
Income from Continuing Operations Before Income Taxes 239 6,891 3,250
Income Tax Benefit (Expense) 53 (1,614) (908)
Income from Continuing Operations 292 5,277 2,342
Income (Loss) from Discontinued Operations, Net of Tax 5 (124) (32)
Net Income 297 5,153 2,310
Net Income Attributable to Noncontrolling Interests (230) (83) (52)
Net Income Attributable to McKesson Corporation $ 67 $ 5,070 $ 2,258
Diluted      
Continuing operations (in dollars per share) $ 0.30 $ 23.28 $ 9.84
Discontinued operations (in dollars per share) 0.02 (0.55) (0.14)
Total (in dollars per share) 0.32 22.73 9.70
Basic      
Continuing operations (in dollars per share) 0.30 23.50 9.96
Discontinued operations (in dollars per share) 0.02 (0.55) (0.14)
Total (in dollars per share) $ 0.32 $ 22.95 $ 9.82
Weighted Average Common Shares      
Diluted (in shares) 209 223 233
Basic (in shares) 208 221 230
EIS, Zee Medical and Nurse Triage Businesses      
Operating Expenses      
Gains from sales of businesses $ 109 $ 0 $ 103
Healthcare Technology Net Asset Exchange      
Operating Expenses      
Gains from sales of businesses 37 3,947 0
Change Healthcare      
Operating Expenses      
Loss from Equity Method Investment in Change Healthcare $ (248) $ 0 $ 0